Small molecule metabolite biomarkers for hepatocellular carcinoma with bile duct tumor thrombus diagnosis

[1]  Yu Yang,et al.  Prognosis of hepatocellular carcinoma patients with bile duct tumor thrombus after hepatic resection or liver transplantation in Asian populations: A meta-analysis , 2017, PloS one.

[2]  Lequn Li,et al.  Clinicopathological characteristics and liver stem cell marker expression in hepatocellular carcinoma involving bile duct tumor thrombi , 2016, Tumor Biology.

[3]  A. Bartlett,et al.  Systematic review and meta-analysis of outcomes after liver resection in patients with hepatocellular carcinoma (HCC) with and without bile duct thrombus. , 2016, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[4]  Jun Zhang,et al.  Radiofrequency Ablation of the Main Lesion of Hepatocellular Carcinoma and Bile Duct Tumor Thrombus as a Radical Therapeutic Alternative , 2015, Medicine.

[5]  R. Palaniappan,et al.  Bile duct thrombi in hepatocellular carcinoma: is aggressive surgery worthwhile? , 2015, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[6]  E. Hatano,et al.  Hepatocellular Carcinoma with Bile Duct Tumor Thrombus: Surgical Outcomes and the Prognostic Impact of Concomitant Major Vascular Invasion , 2015, World Journal of Surgery.

[7]  A. Raza,et al.  Hepatocellular carcinoma review: current treatment, and evidence-based medicine. , 2014, World journal of gastroenterology.

[8]  Poonam Sharma,et al.  Efficacy of Trans-2-Hydroxycinnamic Acid Against Trichlorfon-Induced Oxidative Stress in Wistar Rats , 2012, Toxicology international.

[9]  U. Förstermann,et al.  Nitric oxide synthases: regulation and function. , 2012, European heart journal.

[10]  Y. Yen,et al.  Serum and Urine Metabolite Profiling Reveals Potential Biomarkers of Human Hepatocellular Carcinoma* , 2011, Molecular & Cellular Proteomics.

[11]  Ping Liu,et al.  Serum and Urine Metabolite Profiling Reveals Potential Biomarkers of Human Hepatocellular Carcinoma* , 2011, Molecular & Cellular Proteomics.

[12]  O. Fiehn,et al.  FiehnLib: mass spectral and retention index libraries for metabolomics based on quadrupole and time-of-flight gas chromatography/mass spectrometry. , 2009, Analytical chemistry.

[13]  Wu Mengchao,et al.  Surgery of hepatocellular carcinoma complicated with cancer thrombi in bile duct: efficacy for criteria for different therapy modalities , 2009, Langenbeck's Archives of Surgery.

[14]  I. Sultana,et al.  Hepatocellular carcinoma (HCC) and diagnostic significance of A-fetoprotein (AFP). , 2009, Journal of Ayub Medical College, Abbottabad : JAMC.

[15]  Wang Yulan,et al.  Metabonomics: a revolution in progress , 2006 .

[16]  Adrian M Di Bisceglie,et al.  Diagnosis of hepatocellular carcinoma. , 2005, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[17]  Q. Ye,et al.  Diagnosis and surgical treatments of hepatocellular carcinoma with tumor thrombosis in bile duct: experience of 34 patients. , 2004, World journal of gastroenterology.

[18]  Y. Jan,et al.  Hepatic Resection for Hepatocellular Carcinoma with Obstructive Jaundice due to Biliary Tumor Thrombi , 2004, World Journal of Surgery.

[19]  G. Honda,et al.  Clinicopathologic evaluation of hepatocellular carcinoma with bile duct thrombi. , 2000, Surgery.

[20]  T. Flatmark,et al.  Generation of Reactive Oxygen Species by Tyrosine Hydroxylase: A Possible Contribution to the Degeneration of Dopaminergic Neurons? , 1997, Journal of neurochemistry.

[21]  PhD Tatsuya Orimo MD,et al.  Hepatectomy for Hepatocellular Carcinoma with Bile Duct Tumor Thrombus, Including Cases with Obstructive Jaundice , 2016, Annals of Surgical Oncology.

[22]  Tang Wei-feng.  Misdiagnosis analysis of hepatocellular carcinoma combined with bile duct tumor thrombi , 2013 .

[23]  T. Hui.  Metabonomics: a Revolution in Progress , 2006 .

[24]  S. Morris.  Regulation of enzymes of the urea cycle and arginine metabolism. , 2002, Annual review of nutrition.

[25]  P. Fitzpatrick,et al.  Tetrahydropterin-dependent amino acid hydroxylases. , 1999, Annual review of biochemistry.

[26]  J. Collazos,et al.  Serum CA 19‐9 and alpha‐fetoprotein levels in primary hepatocellular carcinoma and liver cirrhosis , 1992, Cancer.